EV-035: A poster from ICAAC 2012

Evolva

A mouse study. But quite an elegant one that hints at the potential of the EV-035 series in antibiotics.

Evolva

  • Topped our upper estimate! Evolva raises CHF 86M ($86M). Cash position now > CHF 100M ($100M). https://t.co/aiPI46jsTK

Sign up to receive our
Press Releases!

Sign up